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Abstract: Tubercular Mycobacteria and Legionella pneumophila are the causative agents of potentially
fatal respiratory diseases due to their intrinsic pathogenesis but also due to the emergence of antibiotic
resistance that limits treatment options. The aim of our study was to explore the antimicrobial activity
of a small ligand-based chemical library of 1255 structurally diverse compounds. These compounds were
screened in a combination of three assays, two monitoring the intracellular growth of the pathogenic
bacteria, Mycobacterium marinum and L. pneumophila, and one assessing virulence of M. marinum.
We set up these assays using two amoeba strains, the genetically tractable social amoeba Dictyostelium
discoideum and the free-living amoeba Acanthamoeba castellanii. In summary, 64 (5.1%) compounds
showed anti-infective/anti-virulence activity in at least one of the three assays. The intracellular assays
hit rate varied between 1.7% (n = 22) for M. marinum and 2.8% (n = 35) for L. pneumophila with seven
compounds in common for both pathogens. In parallel, 1.2% (n = 15) of the tested compounds were able
to restore D. discoideum growth in the presence of M. marinum spiked in a lawn of food bacteria. We
also validated the generality of the hits identified in the A. castellanii-M. marinum anti-infective screen
using the D. discoideum-M. marinum host-pathogen model. The characterization of anti-infective and
antibacterial hits in the latter infection model revealed compounds able to reduce intracellular growth
more than 50% at 30 ฀M. Moreover, the chemical space and physico-chemical properties of the anti-
M. marinum hits were compared to standard and candidate Mycobacterium tuberculosis (Mtb) drugs
using ChemGPS-NP. A principle component analysis identified separate clusters for anti-M. marinum
and anti-L. pneumophila hits unveiling the potentially new physico-chemical properties of these hits
compared to standard and candidate M. tuberculosis drugs. Our studies underscore the relevance of
using a combination of low-cost and low-complexity assays with full 3R compliance in concert with a
rationalized focused library of compounds to identify new chemical scaffolds and to dissect some of their
properties prior to taking further steps toward compound development.
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Tubercular Mycobacteria and Legionella pneumophila are the causative agents of
potentially fatal respiratory diseases due to their intrinsic pathogenesis but also due
to the emergence of antibiotic resistance that limits treatment options. The aim of
our study was to explore the antimicrobial activity of a small ligand-based chemical
library of 1255 structurally diverse compounds. These compounds were screened in a
combination of three assays, two monitoring the intracellular growth of the pathogenic
bacteria, Mycobacterium marinum and L. pneumophila, and one assessing virulence of
M. marinum. We set up these assays using two amoeba strains, the genetically tractable
social amoeba Dictyostelium discoideum and the free-living amoeba Acanthamoeba
castellanii. In summary, 64 (5.1%) compounds showed anti-infective/anti-virulence
activity in at least one of the three assays. The intracellular assays hit rate varied between
1.7% (n = 22) for M. marinum and 2.8% (n = 35) for L. pneumophila with seven
compounds in common for both pathogens. In parallel, 1.2% (n = 15) of the tested
compounds were able to restore D. discoideum growth in the presence of M. marinum
spiked in a lawn of food bacteria. We also validated the generality of the hits identified in
the A. castellanii–M. marinum anti-infective screen using the D. discoideum–M. marinum
host–pathogen model. The characterization of anti-infective and antibacterial hits in
the latter infection model revealed compounds able to reduce intracellular growth
more than 50% at 30 µM. Moreover, the chemical space and physico-chemical
properties of the anti-M. marinum hits were compared to standard and candidate
Mycobacterium tuberculosis (Mtb) drugs using ChemGPS-NP. A principle component
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analysis identified separate clusters for anti-M. marinum and anti-L. pneumophila hits
unveiling the potentially new physico-chemical properties of these hits compared to
standard and candidate M. tuberculosis drugs. Our studies underscore the relevance
of using a combination of low-cost and low-complexity assays with full 3R compliance
in concert with a rationalized focused library of compounds to identify new chemical
scaffolds and to dissect some of their properties prior to taking further steps toward
compound development.
Keywords: Mycobacterium, Legionella, anti-infective, ChemGPS, amoebae
INTRODUCTION
The emergence of frequent antibiotic-resistant bacteria is
reaching a critical point. Classical strategies to identify new
antibiotics based on their inhibitory effect on in vitro bacterial
growth were successful during the 50–60s to identify the
main antibiotic classes used today, but they are now reaching
their limits. The vast majority of promising chemical scaffolds
identified in vitro and/or against validated molecular targets
failed to show anti-infective activity in infected cells or organisms.
This is due largely to unfavorable pharmacokinetic properties
or toxicity problems that are revealed at later stages during
animal testing or clinical trials. It is necessary today to design
new screening procedures, as well as new chemical libraries
(Pethe et al., 2010). In addition, the development of new curative
treatments against pathogenic bacteria coupled to rationalized
political choices constitutes a major challenge for the future of
public health (Carlet et al., 2014; Perez et al., 2015).
Over the years, millions of compounds have been synthesized
or extracted from natural sources worldwide and are now
available for biological screens (Farnsworth et al., 1985; Diop
et al., 2018). In addition, the general concept behind the re-
screening or repurposing of compounds with new assay systems
is that small molecules have an intrinsic ability to interact with
different targets with different potency and that an identified
chemical scaffold can be developed for a new indication. At
the same time, new phenotypic screening methodologies have
been established, allowing the detailed study of small molecules
interfering with host–pathogen interactions (Wambaugh et al.,
2017). These types of assays are amenable to low or medium
throughput screens. Taking into account the availability of
compounds and the existence of new assays, two strategies
can potentially be followed. The first one is based on random
screening of millions of compounds, while the second one
is based on screening a representative selection enriched for
potential hits by using a virtual screening approach (Westermaier
et al., 2015). Random, high throughput screening (HTS)
campaigns yield a hit rate of ∼1% and are expensive. Screening
a selected database yields similar hit rates at a lower cost, with
a maximized chemical backbone diversity, and allows the use
of low to medium throughput screening systems (Macarron
et al., 2011). Indeed, for the design of such small, highly diverse
libraries, chemical information scientists have identified unique
scaffolds by analyzing the chemical diversity of all the available
compounds. Furthermore, microbiology provides information
on the pathways and their ligands involved in host–pathogen
interactions that allow enriching the highly diverse library with
compounds possessing a pharmacophore known to interact with
targets of these pathways (Loregian and Palu, 2013).
In drug discovery projects, the chemical entities that
are prioritized for biological assessment may encompass
a large chemodiversity. In order to visualize the various
physico-chemical properties of these compounds, various
descriptors such as molecular mass, lipophilicity, and topological
features can be computed. They are used to define a multi-
dimensional descriptor space known as “Chemical space”
(Saldivar-Gonzalez et al., 2019). ChemGPS-NP is an eight-
dimensional standardized space that can contribute to compound
selection and prioritization notably by cluster analysis and
neighborhood mapping (Rosen et al., 2009). Previous studies
used the chemical space navigation tool ChemGPS-NP to
compare 60 anti-mycobacteria-active natural products and 39
anti-Mtb drugs and drug candidates with respect to physico-
chemical properties and their occupation of chemical space. In
physico-chemical space, both sets largely overlapped and defined
a sub-region of Chem-GPS-NP space (Liu et al., 2016).
In recent years, several phenotypic screens performed
in the context of infected animal host cells have identified
compounds active against pathogenic mycobacteria and
Legionella pneumophila (Escoll et al., 2013; Foo et al., 2018;
Machelart et al., 2019). Interestingly, elucidation of the mode of
action of hits revealed that intracellular bacteria proliferation
can be affected by targeting bacterial metabolic pathways key
to their intracellular life, but also by modulating host pathways
(Sundaramurthy et al., 2014; Delorme et al., 2015; VanderVen
et al., 2015). Alternative screening systems have also been
established to take advantage of previously underexplored
cellular amoeba host models (Harrison et al., 2013, 2015a,b;
Kicka et al., 2014). Free-living amoebae (FLA), naturally present
in soil and water, predate on bacteria and fungi that they ingest by
phagocytosis (Cosson and Soldati, 2008; Scheid, 2014). Indeed,
amoebae share ecological niches with most bacteria, and are
putative cellular reservoirs for pathogenic bacteria (Greub et al.,
2004; Hilbi et al., 2007). In addition, FLA have been described
as “trojan horses” for many pathogens including Legionella
and mycobacteria species (Molmeret et al., 2005). Due to the
extreme conservation of phagosomal composition and function
with human phagocytic cells (Boulais et al., 2010), Dictyostelium
discoideum is used as a host cell to investigate interactions with
pathogenic bacteria such as Salmonella,Mycobacteria, Legionella,
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or Pseudomonas (Solomon et al., 2003; Steinert and Heuner,
2005; Hagedorn and Soldati, 2007; Dunn et al., 2018). It has
also been used to identify anti-virulence compounds against
Pseudomonas aeruginosa (Bravo-Toncio et al., 2016).
At the cellular level, L. pneumophila and Mycobacterium
marinum subvert cellular compartments and machineries to
establish a permissive replication niche. After their uptake
by the host cell, each pathogen develops specific strategies.
M. marinum, like Mycobacterium tuberculosis (Mtb), induces
phagosomematuration arrest and restricts its acidification. Then,
the phagosome becomes an active interface between the host cell
and the mycobacteria, by interacting with host machineries such
as autophagy, endosomal, and other compartments, and finally
loses its integrity, giving M. marinum access to the host cytosol
(Cardenal-Munoz et al., 2017, 2018; Lopez-Jimenez et al., 2018).
On the other hand, L. pneumophila establishes a structurally
unique spacious vacuole, the LCV, that intimately interacts with
the host endoplasmic-reticulum compartment (Escoll et al., 2013;
Prashar and Terebiznik, 2015; Steiner et al., 2018; Swart et al.,
2018). To establish the LCV, Legionella deeply modifies the host
vesicular traffic by delivering, via a type-IV secretion system,
a panel of effectors interacting with host components (Finsel
and Hilbi, 2015; Simon and Hilbi, 2015). In addition, the fates
of each pathogen are also different. L. pneumophila resides and
proliferates in the LCV and bacteria are possibly released by
host cell lysis, while M. marinum escapes to the cytosol and
finally egresses the host cell using various routes including a
specific structure named “ejectosome” (Hagedorn et al., 2009).
In the present study, we focused on two pathogenic bacteria
that currently represent a human threat: L. pneumophila, the
causative agent of a severe pneumonia known as legionellosis
or Legionnaires’ disease (Cunha et al., 2015), and M. marinum,
a close relative to Mtb that causes tuberculosis, a major
health burden in human populations (Dheda et al., 2016).
Both mycobacteria are considered facultative intracellular species
because of their capacity to grow within the host cell and also in
the extracellular space or the environment.
Since the primary target of Mtb is macrophages, amoebae that
are also professional phagocytes, are a rational choice to study
host–pathogen interactions. For example, D. discoideum and
Acanthamoeba castellanii were used to characterize compounds
of the GlaxoSmithKline (GSK) TB-set of anti-mycobacterial
compounds (Trofimov et al., 2018). This study showed that
most compounds previously selected for their antibiotic activity
against Mtb and Mycobacterium smegmatis (Ballell et al.,
2013) were active against the closely related M. marinum,
but showed little or no activity in the intracellular context
of an infection. Most importantly, it demonstrated that
compounds with anti-infective activities were similarly active
in the M. marinum–amoebae system and the more standard
M. marinum–macrophage model. This study also underlined
the relevance of using evolutionary distant pathogen and host
models to reveal conserved mechanisms of virulence and defense
(Trofimov et al., 2018).
Here, we tested compounds derived from a unique ligand-
based virtual screen to determine their anti-infective properties
in the two infection models A. castellanii–L. pneumophila
(referred to as “AcLp screen”) and A. castellanii–M. marinum
(referred to as “AcMm screen”) for their abilities to inhibit
intracellular growth. In parallel, the “anti-virulence” activity of
the compounds was determined by monitoring their capacity at
reverting the growth arrest of D. discoideum on lawns of food
bacteria spiked with pathogenic M. marinum (referred to as
“DdMm screen”). Finally, the potency, specificity, and toxicity
of the hits were evaluated. In addition, we conducted further
analyses to evaluate the drug-like properties and chemical space
of the anti-mycobacterial and anti-Legionella hit compounds
using ChemGPS-NP.
RESULTS
Design of a Chemically Highly Diverse
Pathway-Based Library of Compounds
Legionella and Mycobacteria interact with a host through
different pathways, which can be searched for potential drug
targets. Instead of focusing on a single target for a drug
design, we have explored the pathways involved in the host–
pathogen interaction process, and not only those having a
significant pathogen–host selectivity ratio. We selected in total
18 host and pathogen pathways as potential pharmacological
targets. Ligands/metabolites known to interfere/interact with
these host and pathogen pathways were identified from the
available literature, and used as queries or search templates to
prepare pharmacophores for launching a campaign of ligand-
based virtual screening (LVS) of the ZINC database1 (Sterling
and Irwin, 2015) using ROCS, a tool from the OpenEye software
package2 (Swann et al., 2011).
Subsequently, we applied the following workflow (Figure 1):
(i) we screened the ZINC lead-like database composed of 2.5
million compounds saving the 25,000 best hits for each query;
(ii) we ranked the hits according to the ROCS TanimotoCombo
score; (iii) we selected the first hit and the following, if they passed
a test of structural dissimilarity, using the Lingo method program
(Vidal et al., 2005), thereby increasing the chemical diversity
and maximizing the coverage of the chemical space of the ZINC
lead-like database; (iv) we chose at most two analogs per series
from each screened pathway, saving 100 selected compounds to
the pool of potential hits composing the physical library for the
experimental screen. The VS of the 18 different pathways yielded
∼1800 compounds of which 1255 were purchased to compose the
final Highly Diverse Pathways-Based Library; we namedHD-PBL
(Westermaier et al., 2015; Slepikas et al., 2016).
Characterization of the Pathways-Based
Library Properties: Chemical Diversity
and Drug Likeness
The chemical diversity of the pathways-based library was
investigated and analyzed on the basis of the Z-matrix calculated
according to Tanimoto’s chemical similarity metrics (Tsim; see
1http://zinc.docking.org/
2http://eyesopen.com/rocs
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FIGURE 1 | (A) Schematic representation of the LVS workflow applied per each pathway. (B) A visualization of the Ligand-based virtual screen of the ZINC lead-like
database; (i) ranking of the 25,000 best virtually screened hits according to the ROCS TanimotoCombo score; (ii) selection of the first hit and then each next one if
structurally dissimilar to already chosen ones by using the Lingo method; (iii) we chose at most two analogs per series from each screened pathway saving 100
selected compounds to the pool of potential hits composing the physical library for the experimental screen.
FIGURE 2 | The heat map of pathways-based library. The Z-matrix was calculated according to Tsim values: Tsim = 0 for total dissimilarity (blue); Tsim = 1 for total
similarity (red).
Figure 2) using Canvas, a tool from the Schrödinger software
package (Sindhikara and Borrelli, 2018). The corresponding
heat map drawn using Netwalker1.0 (Komurov et al., 2012)
clearly shows that the library is highly diverse (Figure 2).
We deliberately limited the number of analogs in the primary
library to concentrate on the validated hits selected from
the different screens. The analysis of the drug likeness of
the compounds composing the library and the comparison
with the known drug-likeness standards (Lipinski et al., 1997;
Lipinski and Hopkins, 2004; Lipinski, 2016) reveals that the
vast majority of the compounds have the properties to be drug-
like (Figure 3).
Screens Characteristics
The 1255 HD-PBL compounds were assayed using three
biological phenotypic screens (see section “Materials and
Methods”). The categories of pharmacophore queries are
indicated in Table 1, and the hallmarks of the various screens are
summarized in Table 2.
Each of the three assays was established and optimized
separately prior to testing the 1255 compounds (Froquet et al.,
2009; Harrison et al., 2013; Kicka et al., 2014). The three
screens were run simultaneously using the same compounds
batch. The compounds’ concentration was adjusted to 30 µM
for the two cell infection screening assays, taking into account
the shielding effect of A. castellanii cells on intracellular
bacteria (Tosetti et al., 2014), whereas a final concentration
of 10 µM was used in the anti-virulence assay monitoring
D. discoideum growth on bacteria lawns (Table 2). Considering
screen stringency variations, the threshold for hit detection
was arbitrarily fixed at a minimum of 20% reduction of the
intracellular growth of M. marinum, and 40% reduction for
intracellular growth of L. pneumophila compared to the DMSO
control. Fluorescence from GFP-producing bacteria was used as
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FIGURE 3 | Physico-chemical prediction of the HD-PBL. The prediction descriptors of the library were performed using the cheminformatics package Canvas to
evaluate the drug-likeness properties of library’s compounds (Ghose et al., 1999). MW: molecular weight, logP: partition coefficient, PSA: polar surface area, nRotB:
number of rotatable bonds, nHBA: number of hydrogen bond acceptors, nHBD: number of hydrogen bond donors.
a readout of intracellular growth for both anti-infective assays in
the A. castellanii host (Figure 4). Briefly, A. castellanii cells were
infected with GFP-producing M. marinum or L. pneumophila.
Intracellular bacteria growth was monitored by measuring the
fluorescence increase using a plate reader with time-points
taken every 3 h for M. marinum, and at various time intervals
for L. pneumophila as indicated in Figure 4. Extracellular
M. marinum growth was inhibited by adding 10 µM amikacin to
the medium, whereas no antibiotic was added to L. pneumophila
since the PYG medium used for infections does not support
extracellular bacterial growth. Examples of the intracellular
bacterial growth curves are presented in Figures 4A,B for
M. marinum and L. pneumophila, respectively. Normalization
and analysis of the data generated in these two screens
were performed as previously reported for the AcMm screen
(Kicka et al., 2014; Ouertatani-Sakouhi et al., 2017) and the
AcLp screen (Harrison et al., 2013) host–pathogen assays,
respectively. In brief, normalization of bacterial growth in
the presence of each compound was calculated related to the
DMSO carrier (=1).
For the plaque assay, a semi-quantitative visual inspection and
scoring of the compounds was applied, as described previously
(Froquet et al., 2009). As shown in Figure 4C, the ability of hits to
restore D. discoideum growth was quantified to range from inert
molecules (=0) to compounds that fully restore host growth (=4).
Following their identification in their respective initial screen,
candidate hits were independently validated at least three times
in their respective assay.
Hit Frequency and Overlap Between
Screens
The two intracellular growth assays used for screening all 1255
compounds resulted in a broad range of inhibitory activities.
The hit rate was considerably higher for L. pneumophila, where
2.8% (n = 35) of the compounds tested at 30 µM showed a
growth inhibition of at least 40%, compared to 1.7% (n = 22)
withat least 20% inhibition forM. marinum (Figures 5A,B). The
DdMm plaque assay screen showed that 1.2% (n = 15) of the
compounds at 10 µM are valuable hits restoring amoeba growth
(Figure 5C). In comparison to infection assays, full restoration
of amoeba growth on a bacteria lawn containing pathogenic
mycobacteria appeared to be more restrictive and identified only
15 hits from the library. Taken together, 64 compounds showed
anti-infective activity in one of the intracellular growth assays
or attenuated mycobacterial virulence, respectively. As depicted
in the Venn diagram, the AcLp screen shared eight hits with
the other two screens, and among these, seven are common for
the two infection assays and only one for the L. pneumophila–
A castellanii test and the phagocytic plaque assay (Figure 5D).
Surprisingly, no hit was common to the two assays using
M.marinum as pathogenic bacterium. Notably, we also identified
a certain number of pro-infective compounds, namely, chemicals
that lead to a significant increase of the intracellular bacterial
numbers compared to the DMSO control. Five pro-infective
compounds were identified with at least twofold increase in the
intracellularM. marinum bacterial load (Figure 5A). In contrast,
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Calcineurin 1 Pyrazolopyrimidines, CN585 Sieber and Baumgrass, 2009; Jayaraman et al., 2010
E3-Ligase HLI98 Yang et al., 2005
AKT-PKB Indoles, pyridopyrimidine, pyrazolopyrimidine,
pyranonapthoquinones, quinolines, azacarabazoles,
oxazole-2-amines
Tardy et al., 2014
PI3K Wortmanin, LY294002, staurosporin, ATP, myricetin, quercetin Walker et al., 2000
Autophagy Small molecule enhancers of rapamycin = SMERs: SMER18 and 28
from, 2007. Diphenylbutylpiperidines—cpds 15d, 15i, 15j
Floto et al., 2007; Sarkar et al., 2007; Chen et al., 2011
ATPase Salicylihalamide A, indole derivatives H+-ATPase; diaryl pyrazole
resorcinol derivatives HSP90 ATPase; adociasulfate-2 kinesin
ATPase
Sakowicz et al., 1998; Sharp et al., 2007; Supino et al., 2008;
Design, 2009
CD36 Cilostazol, sulfo-N-succinimidyl derivatives Coort et al., 2002
ABC transporters Verapamil, LY335979, OC144-093 Sharom, 2008
Trp CdRP + IGP; ATB107 IGPS target Hennig et al., 2002; Shen et al., 2009
Cys WNI tripeptide; 3-hydroxybutanoic acid, 5-oxohexanoic acid,
4-methyl valeric acid—O-acetyl serine synthethase target
Salsi et al., 2010
His PRPP; PR-ATP; cpds 4 6 17 18; dicoumerol ATP-PRT target Dall-Larsen et al., 1976; Cho et al., 2008
Gln Purine analog; glutamine synthetase target Nilsson et al., 2009
Lipase Orlistat, glimepiride Bertrand et al., 2010; Bustanji et al., 2011; Christelle et al.,
2011; Pedicord et al., 2011; Schalk-Hihi et al., 2011
FAS-II Triclosan, triclocarbon Lu et al., 2011
Cations pumps Acetazolamide, zonisamide, topiramate, phenytoin, lamatrigine,
sumatriptan, verapamil
Long et al., 2005; Wu et al., 2010; Payandeh et al., 2011
Proteasome Lactacystin, omuralid, MG-132, morphine Yang et al., 2008; Yoshida et al., 2009
MeC Spongotine A, bromotopsentin, bromodeoxytopsentin,
cis-3,4-dihydrohamacanthin B
Zoraghi et al., 2011
Porins Cadaverine, putrescine, spermine Iyer et al., 2000
The corresponding pharmacophores of the queries molecules have been used as reference molecules for the ligand-based virtual screen. Each pathway-based screen
resulted in 100 new potential hits.
the AcLp assay identified only one compound that increased
the intracellular growth more than 40% when compared to the
DMSO control (Figure 5B).
Effect of Hit Compounds on Amoeba
Fitness
To evaluate the effect of hit compounds (referred to as “hits”)
on host fitness, we used D. discoideum cells expressing a GFP
construct to measure toxicity and growth inhibitory activities of
compounds (Trofimov et al., 2018). In parallel, a cell viability
test using Alamar blue was performed using A. castellanii 4 h
after hit compound addition at a 30 µM concentration. For each
assay, values were normalized to the DMSO carrier control (= 1).
The compounds’ toxicity and growth inhibition data for each
phenotypic screen are represented in Figures 6A–C.
Only one compound (ZINC01718072) was excluded from
further analysis, because its strong fluorescence at the GFP
emission wavelength confounded the results. At the end, five hits
did not pass the set threshold (less than 40% growth inhibition
or 40% toxicity when compared to DMSO control) and were
rejected for this deleterious effect on host fitness.
Properties of the Hits
To determine whether hits had antibiotic properties, we
measured their activity against M. marinum or L. pneumophila
growing in broth. Compounds at 30 µM in DMSO were
transferred to 96-well plates containing 105 GFP-producing
M. marinum or L. pneumophila per well. Growth was monitored
for 48 hours, and the total fluorescence intensity was used as a
proxy to quantify the bacterial numbers. In parallel, we tested
the ability of hits identified by the phagocytic plaque assay to
directly inhibit M. marinum growth on agar at 10 µM. The
normalized results (DMSO = 1) of the hits detected during cell
infection assays are shown in Figures 7A,B for M. marinum
and L. pneumophila, respectively. In summary, none of 21 hits
exhibited antibiotic properties against M. marinum, whereas 18
of the 35 hits against intracellular L. pneumophila showed an
antibiotic activity. Lastly, 11 compounds out of fifteen from the
anti-virulence hits against M. marinum exhibited mild to strong
antibiotic activity when assayed for bacterial growth inhibition on
agar (Figure 7C).
The D. discoideum–M. marinum
Host–Pathogen Model System
To validate the generality of the anti-infective screen performed
using the AcMm system, we tested the 21 identified hits using
the DdMm host–pathogen model. Fourteen compounds out of
21 exhibited at least a 20% inhibitory activity on intracellular
mycobacteria (Figure 8A). Interestingly, from the hits identified
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TABLE 2 | Screen assays characteristics.
A Anti-infective screens Anti-virulence
screen
Host A. castellanii and
D. discoideum
A. castellanii D. discoideum
Pathogen M. marinum L. pneumophila M. marinum (mixed
1:50 with
K. pneumoniae)











30 µM (solution) 10 µM (agar)
B Hit categories
Anti-infective Yes Yes Possiblya)
Anti-virulence Yes Yes Yes
Pro-infective Yes Yes No
Antibiotic Yesb) Yesb) Yes (mycobacteria-
specific)
Defense booster Yes Yes Yes
a)Further investigations are needed to disentangle whether the activity of the
compound is affecting the extracellular or the intracellular bacteria. b)The anti-
infective screen on M. marinum detected mainly hits with low antibiotic activity,
whereas the screen on L. pneumophila detected mainly potent antibiotics.
in the “extracellular” anti-virulence plaque assay, almost 50%
(7/15) of the compounds showed a growth inhibitory effect
on mycobacteria when tested in the intracellular D. discoideum
infection model. Curiously, the antibiotic potency of these hits, as
detected using growth of bacteria on agar, was barely detectable
in the 2-days bacteria growth assay in suspension, and only
two compounds showed an inhibition intra- and extracellularly
(Figure 8B—dots on the edge of quadrant 1).
Classification and Clustering of
Anti-M. marinum Hits,
Anti-L. pneumophila Hits, and Anti-Mtb
Drugs Using CHEM-GPS
In order to evaluate the distribution of the 1255 compounds
and hits from the HD-PBL in the physicochemical space,
we used the chemical global positioning system of natural
product (ChemGPS-NP; Larsson et al., 2007; Rosen et al.,
2009). ChemGPS-NP is a global chemical positioning system
that utilizes eight standardized dimensions, similar to principal
components (PC) to describe the physico-chemical properties
of compounds, and is specifically tuned for the exploration of
the biologically relevant chemical space of natural products.
We used this tool to compare the compounds described in
the present study with known standard and candidate anti-
Mtb drugs (including both marketed and promising compounds
presently in clinical trials; Dashti et al., 2014), as well as the
compounds and hits from the GSK TB set (Trofimov et al.,
2018), together with the 211,000 compounds from the in silico
MS/DS Database (ISDB). The ChemGPS-NP eight-dimensional
output was explored by inspecting every pair of dimensions.
Eventually, the two-dimensional representation provided by
t-distributed stochastic neighbor embedding (tSNE) was utilized
to visually summarize the ChemGPS-NP analysis. Figure 9A
clearly shows that the drug-like properties of anti-Mtb drugs
(black dots) are remarkably scattered on the full ISDB reference
cloud, possibly indicating a large variety of mode of actions
and targets. The 1255 compounds from the HD-PBL (orange)
and the 177 from the GSK TB set (green) formed two separate
clouds that occupy a much more restricted subspace compared
to the anti-Mtb drugs. The hits from HD-PBL (orange dots—
anti-M. marinum hits, blue dots—anti-L. pneumophila hits,
and orange dots with a blue center—hits active against both
M. marinum and L. pneumophila) appeared dispersed inside the
cloud of the HD-PBL, and surrounded by standard and candidate
anti-Mtb drugs (black dots). However, closer inspection revealed
that some HD-PBL hits formed two sub-clusters (box A and
B) separated from the other HD-PBL hits. In addition, 3 HD-
PBL hits (arrows) stand further apart, indicating a distinct
structural scaffold. A hierarchical classification of standards and
candidate anti-Mtb drugs (black), together with the hits from
the GSK TB set (green), and HD-PBL (orange) was computed
using average linkage of Euclidian distances in the original
ChemGPS-NP space (Figure 9B). This classification confirmed
the structural differences existing between the various standard
and candidate anti-Mtb drugs, which also appeared dispersed in
the dendrogram. Overall, the hits from the GSK TB set and HD-
PBL appear to have diverse structural scaffolds and are distributed
along the dendrogram. Interestingly, a mixed group of hits from
GSK TB set (N = 10) and of HD-PBL (N = 12) clustered on the
right of the dendrogram, likely exhibiting distinctive structural
properties from the known anti-Mtb drugs.
DISCUSSION
Results From the Screening of the
HD-PBL Reflect Pathogen Specificities
and Assay Characteristics
Virtual screening is an efficient strategy to bypass the hurdle
of evaluating large libraries of compounds by selecting the
supposedly best candidates, and reducing the number of in vitro
and in vivo experiments. Mycobacteria and Legionella infections
are described as a complex and dynamic series of interactions
between multiple host and bacterial components and pathways.
In order to create our HD-PBL, we selected a total of 18
host and pathogen pathways as potential pharmacological
targets, and an LVS of the ZINC database was launched to
identify ligands/metabolites known to interfere/interact with
these pathways. In our study, we tested 1255 compounds from
the ZINC lead-like database derived from a unique LVS to
determine their anti-infective properties. For this purpose, a
combination of three phenotypic assays was used, as summarized
in Table 2. Two assays monitored the intracellular growth of
(1) M. marinum and (2) L. pneumophila in A. castellanii and
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FIGURE 4 | A representative selection of the HD-PBL compounds tested in
the three different assays. Phagocytic host cell A castellanii was infected with
(A) M. marinum msp12:GFP and (B) GFP-expressing L. pneumophila,
5 × 104 infected cells were transferred to each well of a 96-well plate. The
course of infection at 25◦C was monitored by measuring fluorescence for 72 h
in the presence of 30 µM of corresponding compounds compared to DMSO
control (green) and 10 µM rifabutin—only for M. marinum assay (black).
(C) Virulence assay. Each compound (10 µM) was added on SM-agar
medium followed by the addition of K. pneumoniae and M. marinum mixture;
1000 D. discoideum cells were deposited in the center of the well and plates
were incubated for 5–9 days at 25◦C and the formation of phagocytic plaques
was monitored visually.
identified antibiotics, potential anti-virulence, and host defense
boosters. In parallel, we used a phagocytic plaque assay (3), in
which a compound restoring growth of D. discoideum on a lawn
of Klebsiella pneumoniae spiked with M. marinum has either
selective antibiotic activity againstM.marinum, or attenuates the
virulence of infectingM. marinum.
We identified 64 compounds showing activity in at least
one of the assays for intracellular bacteria growth inhibition,
or attenuation of mycobacterial virulence (Supplementary
Table S1). Although the same host was used for the two
infection assays, only few hits were common againstM. marinum
and L. pneumophila. The number of identified hits was
considerably higher for L. pneumophila compared toM.marinum
(Figures 5A,B). While no strong antibiotic hit was identified
using the AcMm model, almost half of the hits identified in the
AcLp screen (16/35) are potent antibiotics. A possible explanation
might be the difference in growth rate between the two bacteria.
L. pneumophila grows almost unrestrictedly inside the amoeba,
with a doubling time close to 3 h, whereas M. marinum is a
considerably slower grower, with a doubling time of around
8 h. A related aspect is the temperature (T = 25◦C) used
for the intracellular assays, which is closer to the optimum
for L. pneumophila. Another plausible reason might be that
the two pathogens have a very distinct cell wall composition.
In contrast to the Gram-negative L. pneumophila cell wall,
M. marinum has an elaborate and highly hydrophobic structure
with unique components such as arabinogalactan, a highly
branched polysaccharide that connects the peptidoglycan with
the outer mycolic acid layer, strongly limiting the permeability to
compounds. In addition, cellular components like efflux pumps
might also play an important role in the bioavailability of
the compounds. Another aspect is the nature of the bacteria
proliferation niche.While L. pneumophila resides and proliferates
in an ER-associated vacuole, M. marinum starts proliferating
in a phagosome-derived vacuole and then continues after
escape to the cytosol.
Surprisingly, the two assays used to identify anti-infective or
anti-virulence compounds against M. marinum did not identify
any common hit. As presented in Table 2B (first and second
column), hits hallmarks are linked to the intrinsic screen design.
Indeed, in the two infection assays, the compounds are added
post-infection, and therefore, compounds that hamper bacteria
uptake cannot be detected. Thus, both assays detect anti-infective
hits that inhibit virulence or boost host defenses. On the
contrary, in the anti-virulence assay (third column, Table 2), the
uptake efficiency of M. marinum might be directly affected by
compounds that either target the host phagocytosis machinery,
or modify the mycobacterial cell wall. In addition, 11 of the 15
anti-virulence hits identified in the phagocytic plaque assay had
selective antibiotic activity againstM. marinum (Figure 7C).
To better understand the contrasting results of the anti-
infective and the anti-virulence screens on M. marinum,
the hits from both primary assays were re-tested in the
DdMm infection assay (Table 2, first column and Figure 8A).
Satisfyingly, two-thirds of the anti-infective hits originally
identified in the A. castellanii assay were confirmed using
the D. discoideum infection assay, likely reflecting the overall
conservation of basic metabolic pathways between these two
evolutionarily close organisms. In contrast, only half of the
anti-virulence hits showed mild but significant activity in the
D. discoideum infection assay (Figure 8B). One possibility is
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FIGURE 5 | Percentage hit rate (A–C) and hits overlap of the three screens. All 1255 compounds were tested for potential intracellular growth inhibition. Library
compounds were plotted based on their anti-infective properties. Compounds resulting in decreased intracellular M. marinum and L. pneumophila replication by over
20 and 40%, respectively, at the screening concentration (30 µM) were defined as hit candidates. (C) Compounds score from the “phagocytic plaque assay.” The
potency of each compound to restore D. discoideum growth was evaluated, hits were determined as molecules that fully restore host growth (=4). (D) Venn diagram
representing summarized results of the primary hits identified from the three assays. The analyzed set included compounds that passed the aforementioned cut-offs.
the presence of an MCV membrane around M. marinum that
restricts the bioavailability of the compounds. In addition,
it is known that M. marinum undergoes drastic metabolic
adaptations to different carbon sources when transitioning
between its extracellular life to the intracellular environment,
possibly explaining the differential sensitivity to the anti-
virulence hits.
Pro-infective Hits, Another Facet to
Better Understand the
Mycobacterium–Host Interactions
On the other hand, identification of infection enhancers in
the set of compounds was quite surprising, although the same
observation was already reported in the phenotypic screen
of the GSK TB set of anti-mycobacterial antibiotics in the
AcMm model of infection (Trofimov et al., 2018). Notably here,
five compounds were identified that increased the intracellular
M. marinum load at least twofold (Figure 5A). As discussed in
the Trofimov et al.’s paper, such compounds may be targeting
and disarming crucial anti-bacterial host defense pathways and
therefore, might lead to a better understanding of these pathways
and might ultimately lead to the design of host-directed anti-
mycobacterial therapies.
Confirmation of the Low Cytotoxicity of
Compounds on D. discoideum
Measurement of the hits’ cytotoxicity/growth inhibition activity
was performed by monitoring the growth of GFP-expressing
D. discoideum. Four out of six compounds that are either
toxic for D. discoideum or affect its growth are common
between two screens (Figures 6A–C). This low number of toxic
compounds might be explained by the fact that the pathways
selected for the LVS are non-essential for host metabolism and
survival. In addition, the LVS likely enriched the library for
compounds with drug-like properties that are anticipated to
have low toxicity. The anti-infective hits with mild cell growth
inhibition activity should be further investigated to optimize their
therapeutic window.
Navigation in the Biologically-Relevant
Chemical Space Identifies a Potential
Structural Class of Anti-mycobacterial
Compounds
The chemical entities that were prioritized for biological
assessment encompassed a large chemodiversity. In order to
visualize the various physico-chemical properties of the tested
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FIGURE 6 | Characterization of cytotoxic and growth inhibitory activities of
primary hits. Primary hits come from the three different screens [(A) AcMm
refers to A. castellanii–M. marinum, (B) AcLp refers to A. castellanii–L.
pneumophila, and (C) DdMm refers to D. discoideum–M. marinum]. Two
different assays were compared, a cytotoxicity test in A. castellanii and a
growth inhibition assay in D. discoideum. Compound cytotoxicity (y-axis in
A–C) against A. castellanii was determined using the Alamar blue reagent. The
corresponding data are presented in Supplementary Table S2 column K.
The growth inhibitory activity of compounds on D. discoideum GFP-ABD was
measured with a fluorescence plate reader (x-axis in A–C). The corresponding
data are presented in Supplementary Table S2 column I. The compounds
were tested at 30 mM and values were normalized to the DMSO carrier
control (=1).
FIGURE 7 | Intracellular and extracellular growth of the pathogenic bacteria in
presence of the primary hits. Growth of M. marinum (A) and L. pneumophila
(B) in the presence of hits (30 µM) was determined for both intracellular
(A. castellanii) and extracellular replication (broth). The graphs indicate the
fluorescence measurements normalized to 1 (vehicle control). (C) Antibiotic
assay. Compounds (10 µM) identified in phagocytic plaques assay were
added to 7H11 medium in each well and then 1000 M. marinum bacteria
were deposited in the well. Growth of mycobacteria was monitored after
6 days at 30◦C.
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compounds, we computed these characteristics using the eight-
dimensional standardized space of ChemGPS-NP. Although this
analysis did not show a clear separation between the hits and non-
hits in each library, two groups of compounds formed distinct
clusters, one containing M. marinum and anti-L. pneumophila
hits (Box A) and a second one containing solely anti-M.marinum
hits with the exception of one compound which belongs to
the anti-L. pneumophila hits (Box B). One might speculate
that Box B highlights compounds that hit mycobacteria-specific
targets, while Box A either contains compounds that hit targets
common to both bacteria or that enhance the activity of host
defenses active against both bacteria. In parallel, the hierarchical
classification identified a promising group of hits clustered away
from the standard and candidate anti-Mtb drugs, suggesting
the existence of a new group of anti-Mtb compounds, which
need to be further studied. This analysis suggests that it might
be interesting to use the ChemGPS-NP analysis to instruct the
initial compound selection and the prioritization steps, notably
by cluster analysis and neighborhood mapping. Mapping of
collections of compounds with reported bioactivities and those
discovered in our studies on such a chemical space will allow to
partly orient the research and can also support SAR studies.
Combination of 3R Model Assays
Increases the Chances of Identifying
Potential Anti-mycobacterial
Compounds
Virtual screening is an efficient traditional strategy for quick
evaluation of large libraries of compounds that permits a focus
on the supposedly best candidates, reducing the amount of
in vitro and in vivo experiments. It has become an integral
part of the drug discovery process, with proven value in several
therapeutic areas. In conclusion, our data show that the LVS
efficiently selected anti-bacterials from the 2.5 Mio lead-like
compounds of the ZINC library, giving rise to hit rates two
to three times superior to the 1% usually observed by random
screening. The data also demonstrate that the validated virtual
hits are chemically diverse, suggesting that they most likely
target different pathways within the host pathogen system. We
suggest that our combination of cost-effective, 3R compliant
amoebae-based phenotypic assays to screen structurally diverse
chemical libraries efficiently identifies a variety of promising
non-toxic anti-infective compounds that then will be validated
in more complex infection systems such as the zebrafish
or mouse models.
MATERIALS AND METHODS
Design and Characterization of the
Chemically Highly Diverse
Pathway-Based Library for Phenotypic
Screening
In recent years, the design of diverse libraries based on
the principle of functional diversity has become a major
trend in library design (Shelat and Guy, 2007). This includes
designing libraries containing privileged structures as well as
diverse scaffolds to best cover the chemical space. In this
work, we selected in total 18 host and pathogen pathways
(Table 1) as potential pharmacological targets to develop
pharmacophores queries based on ligands/metabolites known
to interfere/intervene within these host and pathogen pathways
(Table 1). These pharmacophore queries have been used in
LVS of the ZINC lead-like database3 (Sterling and Irwin, 2015)
using ROCS, a tool from the OpenEye software package4 (Swann
et al., 2011). The ligand-based VS was performed with ROCS
using previously published default settings (Kirchmair et al.,
2009) and the TanimotoCombo score. To ensure chemical
diversity and maximize the coverage of the chemical space of
the ZINC lead-like database, we applied the Lingo method
program (Vidal et al., 2005). We screened the ZINC lead-
like database composed of 2.5 million compounds and finally
selected 100 compounds per host and pathogen pathways for
a total of 1800 compounds using the workflow described
in Figure 1. Thus, the selected virtual hits correspond to
0.07% of the whole ZINC lead-like database. The number of
virtual hits was tractable by the medium throughput assays
described in this work.
The pathways-based library properties were characterized
in term of chemical diversity and drug likeness. To
assess chemical diversity, we used the Z-matrix calculated
according to Tanimoto’s chemical similarity metrics (Tsim)
using Canvas, a tool from the Schrödinger software
package (Sindhikara and Borrelli, 2018). The results have
been displayed as a heat map drawn using Netwalker1.0
(Komurov et al., 2012). The drug-likeliness of compounds
of the library was assessed by predicting physico-chemical
descriptors using Canvas (Ghose et al., 1999) and
comparing them with the different known rules in drug
discovery (Lipinski et al., 1997; Lipinski and Hopkins, 2004;
Lipinski, 2016).
Bacterial and Cell Cultures
Acanthamoeba castellanii (ATCC 30234) was grown in PYG
medium at 25◦C as described (Moffat and Tompkins, 1992; Segal
and Shuman, 1999) using proteose peptone (Becton Dickinson
Biosciences) and yeast extract (Difco). The D. discoideum strain
was grown in HL5c medium at 22◦C.
Legionella pneumophila were re-suspended from plates in
appropriate growth medium, ACES Yeast Extract (AYE),
and diluted to a starting OD600 of 0.01. Compounds were
added to these cultures such that the maximal DMSO
concentration was 0.1%. Cultures were grown overnight and the
OD600 was measured.
Mycobacterium marinum were cultured in Middlebrook
7H9 (Difco) supplemented with 10% OADC (Becton
Dickinson), 0.5% glycerol, and 0.2% Tween80 (Sigma–
Aldrich) at 32◦C in shaking culture. The M. marinum
strain constitutively expressing GFP was obtained by
3http://zinc.docking.org/
4http://eyesopen.com/rocs
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FIGURE 8 | Comparison of two amoeba host models. (A) Comparison of anti-infective properties of primary hits on intracellular M. marinum growth in D. discoideum
and A. castellanii host cells. (B) Selected anti-virulence hits plotted based on their anti-infective (20% inhibition) and anti-bacterial (40%) activity in D. discoideum–M.
marinum model. 105 D. discoideum cells infected with M. marinum msp12:GFP were transferred to the wells, hits were added at 30 µM. The fluorescence intensities
were measured for 72 h every 3 h.
transformation with msp12:GFP, and cultivated in the presence
of 30 µg/ml kanamycin.
Intracellular Replication of M. marinum
in A. castellanii
Acanthamoeba castellanii were cultured in PYG medium in
10 cm Petri dishes at 25◦C, and passaged the day prior to
infection to reach 90% confluence. M. marinum were cultivated
in a shaking culture at 32◦C to an OD600 of 0.8–1 in 7H9
medium. Mycobacteria were centrifuged at RT at 500 g for
two periods of 10 min onto a monolayer of Acanthamoeba
cells at an MOI of 10 to promote efficient and synchronous
uptake, followed by an additional 20–30 min incubation. Un-
ingested bacteria were washed off with PYG and infected cells
re-suspended in PYG containing 10 µM amikacin; 5 × 104
infected cells were transferred to each well of a 96-well plate
(Cell Carrier, black, transparent bottom from Perkin Elmer) with
pre-plated compounds and controls. The course of infection
at 25◦C was monitored by measuring fluorescence in a plate
reader (Synergy H1, BioTek) for 72 h with time points taken
every 3 h. Only experiments with a Z-factor > 0.6 (calculated
from DMSO and rifabutin controls) were taken into account for
analysis. Time courses were plotted and data from all time points
(using cumulative curves) were used to determine the effect of
compounds versus vehicle controls. The primary hit rate cut off
was set at 20% inhibition forM. marinum.
Intracellular Replication of M. marinum
in D. discoideum
Dictyostelium discoideum were cultured in HL5c medium in
10 cm Petri dishes at 22◦C, and passaged the day prior to
infection to reach 90% confluency. Mycobacteria were grown
in 7H9 medium to a density of OD600 = 0.8–1.0 (5 × 10
8
bacteria ml−1), centrifuged and re-suspended in HL5c medium
and clumps disrupted by passaging through a 25−gauge needle.
GFP-expressing M. marinum were added at an MOI of 10 and
centrifuged onto theDictyostelium cells at 500 g twice for 10 min.
The cells were left at 25◦C for an additional 10–20 min before
uningested bacteria were washed off by three washes with HL5c
and attached cells were then re−suspended in HL5c containing
10 µM amikacin. The course of infection was monitored as
described above.
Intracellular Replication of
L. pneumophila in A. castellanii
Acanthamoeba castellaniiwere cultured in PYGmedium at 25◦C,
and passaged the day prior to infection such that 2 × 104 cells
were present in each well of a 96-well plate (Cell Carrier,
black, transparent bottom from Perkin Elmer). Cultures of
L. pneumophila harboring the GFP-producing plasmid pNT-28
(Tiaden et al., 2007) were re-suspended from plate to a starting
OD600 of 0.1 in AYE medium, and grown overnight in shaking
conditions at 37◦C to an OD600 of 3. Re-suspended bacteria in
LoFlo medium (ForMedium) were centrifuged onto a monolayer
of A. castellanii cells at an MOI of 20 to promote efficient and
synchronous uptake. Compounds were added to at least triplicate
wells after infection, and infected cells were incubated at 30◦C.
GFP fluorescence was measured by a plate spectrophotometer at
appropriate intervals (Optima FluoStar, BMG Labtech). Because
the culture media used for A. castellanii do not support the
growth of L. pneumophila, GFP fluorescence accurately reflects
intracellular replication. The hit rate cut off was set at 40%
inhibition for L. pneumophila. Time courses were constructed,
and data were used to determine the effect of compounds versus
vehicle control.
Anti-virulence Assay Against M. marinum
To test the effect of the compounds on M. marinum virulence,
10 ml of mid-log phase mycobacterial cultures (OD600 around
0.8–1.2) were pelleted by centrifugation and re-suspended in 5 ml
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FIGURE 9 | ChemGPS-NP analysis of anti-Mtb hits. (A) ChemGPS-NP-based analysis of the chemical space occupied by 211,000 compounds extracted from
ISDB (gray background), the standard and candidate anti-Mtb drugs (black dots), the HD-PBL (orange cloud = non-hits, orange dots = anti-M. marinum hits, blue
dots = anti-L. pneumophila hits, orange dots with a blue center = hits active against both M. marinum and L. pneumophila), and the GSK TB set (green
cloud = non-hits, green dots = anti-M. marinum hits). To improve visualization, 2D t-distributed stochastic neighbor embedding (tSNE) was applied to the eight
output PCs of ChemGPS-NP. (B) Hierarchical classification of anti-mycobacterial compounds computed using the Euclidian distance in the Chem-GPS-NP space
with average linkage: standard and candidate anti-Mtb drugs (black); GSK TB set hits (green); HD-PBL hits (orange). The dendrogram illustrates the arrangement of
the clusters produced by the complete linkage clustering method.
Frontiers in Microbiology | www.frontiersin.org 13 February 2020 | Volume 11 | Article 266
Hanna et al. Identification of Anti-Mycobacterium and Anti-Legionella Compounds
of an overnight culture of K. pneumoniae (KpGe; Lima et al.,
2018) diluted to 1/10,000 in LB medium (Alibaud et al., 2011).
The mixture was de-clumped by passaging through a 25-gauge
blunt needle. In each well of a 24-well plate, 10 µM of each
compound was added and allowed to diffuse on 2 ml of solid
standard medium (SM) agar supplemented with glucose followed
by the addition of 50 µl of the bacterial suspension Once dried,
1000 D. discoideum cells were added in the center of the well.
Plates were incubated for 5–9 days at 25◦C and the formation
of phagocytic plaques was monitored visually, a negative control
(Bacteria + D. discoideum + DMSO) was included in every plate.
Antibiotic Activity Assays
Antibiograms used tomonitor the inhibitory effect of compounds
onmycobacterial growth were performed as described previously
(Ouertatani-Sakouhi et al., 2017), each molecule was added in
a 24-well plate well containing 2 ml of 7H11 agar medium
at 10 µM. Once dried, 1000 bacteria were deposited in each
well and plates were incubated at 32◦C for 7 days to allow
bacterial growth.
To monitor M. marinum growth, GFP-producing bacteria
were cultivated in shaking at 32◦C in 7H9medium supplemented
with OADC up to an OD600 of 0.8–1. 10
5 GFP-producing
M. marinum were transferred into each well of 96-well white
plates. To monitor L. pneumophila growth, a pre-culture of GFP-
producing bacteria was diluted to a starting OD600 of 0.01 and
grown overnight. Compounds at 30 µM in DMSO were added in
each well, seeded with 100 µl of pre-culture, and bacterial growth
was monitored for at least 48 h by measuring the fluorescence in
a plate reader (Synergy H1) every 3 h.
D. discoideum Growth Inhibition Assay
104 GFP-ABD-expressing Dictyostelium cells were transferred
to each well of 96-well plates allowed to attach for
20–30 min. Cell growth at 25◦C was monitored by
measuring the GFP fluorescence in a fluorescent plate
reader (Synergy H1, company) for 72 h with the time
point every 3 h.
Cytotoxicity Assay
Cytotoxicity of compounds against A. castellanii was determined
using the Alamar Blue reagent (Life Technologies). To mimic
the conditions found in the intracellular replication assay, 96-
well plates were set up as previously described and uninfected
triplicate wells were treated with compounds in 100 µl LoFlo
media (Harrison et al., 2013). Plates were incubated at 30◦C
for 24 h, after which 10 µl Alamar Blue reagent was added,
and plates incubated for a further 3 h. The fluorescence
at 595 nm was measured, and data normalized between 1
(treatment with LoFlo alone) and 0 (SDS, total lysis of the
cells). Means from each individual experiment were then
combined for analysis.
ChemGPS Analysis
ChemGPS-NP is a PC analysis (PCA)-based model that
serves as a tool for navigation in the biologically-relevant
chemical space. It is composed of eight PCs based on 35
chemical descriptors, which represent physico-chemical
properties such as size, shape, flexibility, rigidity, polarizability,
lipophilicity, polarity, and hydrogen bonding capacity5 (Larsson
et al., 2007; Rosen et al., 2009). The prediction scores were
calculated based on the structural information derived
from SMILES using the ChemBioDraw software. All salts,
hydration information, and counterions were excluded from
the SMILES annotation, and differences in stereochemistry
ignored, since ChemGPS-NP only uses two-dimensional
descriptors. For visualization in 2D, tSNE was applied to the
eight output PCs from ChemGPS-NP on the ISDB library,
standard and candidate anti-Mtb drugs, the GSK TB set,
and the HD-PBL. In a second approach, tSNE was applied
on the above libraries, excluding the ISDB reference library.
The tSNE computation was performed using a perplexity
value of 50 and a maximum number of iterations of 500.
To ensure reproducibility, a fixed seed was used for tSNE,
as well as for random subsampling the large ISDB reference
library (Maaten and Hinton, 2008). For visualization, the
resulting dimensions were represented in a scatter plot, and
complemented by a 2D density estimation (density_stat_2d
function of package ggplot2). The following programs,
packages, and versions were used: R (version 3.6.0), Rstudio
(version 1.2.1335), package Rtsne (version 0.15), package dplyr
(version 0.8.3), package ggplot2 (version 3.2.1), package MASS
(version 7.3-51.4).
Data Analysis
Data analysis was performed using Microsoft Excel and
GraphPad Prism 7. To compare the effect of compound
treatment on intracellular replication, fluorescence values
were taken from the first time point following entry to
stationary phase. The results were then normalized such
that media-only wells (no bacteria) were “0,” while vehicle-
treated wells were “1” (normal replication). The average
of the replicate wells (minimum three per plate) was then
plotted as dose–response curves, such that each individual
point represented the average of a single experiment.
Compound treatments were repeated a minimum of three
times to control for the increased variability of bacteria–host
cell interactions.
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